Plante Moran Financial Advisors Decreased By $1.14 Million Its Intel (INTC) Stake; Intercept (ICPT)’s Sentiment Is 1.31

May 21, 2018 - By Neil V. Hobbs

Intel Corporation (NASDAQ:INTC) Logo

Plante Moran Financial Advisors Llc decreased Intel Corp (INTC) stake by 48.55% reported in 2017Q4 SEC filing. Plante Moran Financial Advisors Llc sold 24,856 shares as Intel Corp (INTC)’s stock rose 9.61%. The Plante Moran Financial Advisors Llc holds 26,339 shares with $1.22 million value, down from 51,195 last quarter. Intel Corp now has $253.88B valuation. The stock increased 1.83% or $0.98 during the last trading session, reaching $54.48. About 11.65M shares traded. Intel Corporation (NASDAQ:INTC) has risen 44.65% since May 21, 2017 and is uptrending. It has outperformed by 33.10% the S&P500.

Intercept Inc (ICPT) investors sentiment decreased to 1.31 in Q4 2017. It’s down -0.02, from 1.33 in 2017Q3. The ratio dived, as 80 investment professionals started new or increased positions, while 61 decreased and sold stock positions in Intercept Inc. The investment professionals in our database reported: 17.97 million shares, down from 18.23 million shares in 2017Q3. Also, the number of investment professionals holding Intercept Inc in top ten positions increased from 0 to 1 for an increase of 1. Sold All: 19 Reduced: 42 Increased: 44 New Position: 36.

Analysts await Intercept Pharmaceuticals, Inc. (NASDAQ:ICPT) to report earnings on July, 30. They expect $-3.06 EPS, up 11.56% or $0.40 from last year’s $-3.46 per share. After $-3.22 actual EPS reported by Intercept Pharmaceuticals, Inc. for the previous quarter, Wall Street now forecasts -4.97% EPS growth.

More notable recent Intercept Pharmaceuticals, Inc. (NASDAQ:ICPT) news were published by: Seekingalpha.com which released: “Intercept: Still Not ‘Intercepting’ At These Levels” on May 16, 2018, also Nasdaq.com with their article: “Report: Developing Opportunities within AG Mortgage Investment Trust, Associated Banc-Corp, Reata Pharmaceuticals …” published on May 18, 2018, Nasdaq.com published: “Intercept to Announce First Quarter 2018 Financial Results on May 8, 2018 and Present at Upcoming Investor …” on May 01, 2018. More interesting news about Intercept Pharmaceuticals, Inc. (NASDAQ:ICPT) were released by: Seekingalpha.com and their article: “Intercept Pharmaceuticals (ICPT) Q1 2018 Results – Earnings Call Transcript” published on May 08, 2018 as well as Streetinsider.com‘s news article titled: “Intercept Pharma (ICPT) Tops Q1 EPS by 20c” with publication date: May 08, 2018.

The stock decreased 1.50% or $1.09 during the last trading session, reaching $71.36. About 160,872 shares traded. Intercept Pharmaceuticals, Inc. (ICPT) has declined 48.35% since May 21, 2017 and is downtrending. It has underperformed by 59.90% the S&P500.

Sarissa Capital Management Lp holds 2.73% of its portfolio in Intercept Pharmaceuticals, Inc. for 182,300 shares. Bb Biotech Ag owns 485,719 shares or 0.8% of their US portfolio. Moreover, Altrinsic Global Advisors Llc has 0.7% invested in the company for 310,300 shares. The New York-based Spark Investment Management Llc has invested 0.57% in the stock. Regal Investment Advisors Llc, a Michigan-based fund reported 30,147 shares.

Intercept Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the development and commercialization of therapeutics to treat non-viral, progressive liver diseases. The company has market cap of $1.81 billion. The Company’s lead product candidate is obeticholic acid , a bile acid analog, which has a structure based on a naturally occurring human bile acid that selectively binds to and activates the farnesoid X receptor (FXR). It currently has negative earnings. The firm is developing OCA to treat various non-viral progressive liver diseases, such as nonalcoholic steatohepatitis, primary sclerosing cholangitis, and biliary atresia.

Among 55 analysts covering Intel Corporation (NASDAQ:INTC), 36 have Buy rating, 3 Sell and 16 Hold. Therefore 65% are positive. Intel Corporation had 264 analyst reports since August 7, 2015 according to SRatingsIntel. As per Tuesday, April 3, the company rating was maintained by Rosenblatt. JMP Securities upgraded the shares of INTC in report on Friday, September 25 to “Mkt Perform” rating. B. Riley & Co maintained the shares of INTC in report on Friday, April 27 with “Buy” rating. The rating was maintained by Credit Suisse on Tuesday, April 3 with “Buy”. The company was maintained on Wednesday, May 31 by Canaccord Genuity. The firm has “Buy” rating by M Partners given on Tuesday, January 23. The firm earned “Sell” rating on Wednesday, January 3 by Rosenblatt. RBC Capital Markets reinitiated the stock with “Sector Perform” rating in Friday, August 28 report. Deutsche Bank maintained Intel Corporation (NASDAQ:INTC) rating on Thursday, July 21. Deutsche Bank has “Buy” rating and $40 target. As per Friday, November 20, the company rating was maintained by UBS.

Investors sentiment decreased to 1.02 in 2017 Q4. Its down 0.01, from 1.03 in 2017Q3. It is negative, as 60 investors sold INTC shares while 703 reduced holdings. 177 funds opened positions while 601 raised stakes. 3.06 billion shares or 0.43% more from 3.05 billion shares in 2017Q3 were reported. Btc Capital Mgmt Incorporated holds 1.13% of its portfolio in Intel Corporation (NASDAQ:INTC) for 142,083 shares. Da Davidson & has 0.76% invested in Intel Corporation (NASDAQ:INTC) for 780,530 shares. Renaissance Investment Grp Ltd Liability Corp holds 0.62% or 33,518 shares in its portfolio. Jolley Asset Management Limited Liability Co reported 7,129 shares. Mason Street Advisors Ltd Liability Company accumulated 651,885 shares. Advisor Prtnrs Ltd stated it has 0.77% of its portfolio in Intel Corporation (NASDAQ:INTC). Harris Lp stated it has 15.14 million shares. Perkins Capital Incorporated invested in 0.3% or 6,850 shares. Stone Ridge Asset Mgmt Ltd Liability Corp invested in 0.29% or 95,965 shares. Tnb Financial accumulated 39,339 shares. 1.05 million are owned by Teachers Retirement System Of The State Of Kentucky. Svcs has invested 0.2% in Intel Corporation (NASDAQ:INTC). Honeywell invested in 0.88% or 576,000 shares. Point72 Asset Mngmt LP accumulated 123,759 shares or 0.02% of the stock. Hayek Kallen Invest holds 3.95% or 130,435 shares in its portfolio.

More notable recent Intel Corporation (NASDAQ:INTC) news were published by: Seekingalpha.com which released: “Intel’s Hot Shares” on May 21, 2018, also Seekingalpha.com with their article: “Intel Delivers” published on May 21, 2018, Seekingalpha.com published: “Intel’s self-driving cars testing in Jerusalem” on May 17, 2018. More interesting news about Intel Corporation (NASDAQ:INTC) were released by: Fool.com and their article: “Better Buy: Micron Technology Inc. (MU) vs. Intel (INTC)” published on May 19, 2018 as well as Fool.com‘s news article titled: “After 6 Years as a Shareholder, Here’s Why I Just Sold My Intel Stock” with publication date: May 20, 2018.

Intercept Pharmaceuticals, Inc. (NASDAQ:ICPT) Institutional Positions Chart

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.

Free Email Newsletter

Enter your email address below to get the latest news and analysts' ratings for your stocks with our free daily email newsletter:


Recent Posts